Mechanism of Action of Entresto (Sacubitril/Valsartan)
Introduction Entresto is a combination drug containing sacubitril, a neprilysin inhibitor, and valsartan, an angiotensin II receptor blocker (ARB). It’s primarily used for the treatment of heart failure with reduced ejection fraction (HFrEF). The combination enhances natriuretic peptide levels while blocking deleterious effects of angiotensin II, working synergistically to reduce mortality and hospitalizations in heart … Read more
